An interesting and perhaps very useful direction. How much is this a diagnosis?
The Doctor Will Hear You Soon By Gregory Goth, Commissioned by CACM Staff
Tal Wenderow knows what it takes to make it big with a technology startup. Wenderow is CEO of Newton, MA-based Vocalis Health, which is developing an artificial intelligence- and machine learning-based platform capable of discerning changes in health through subtle changes in a person's voice.
His last venture, robotic surgery vendor Corindus Vascular Robotics, was acquired by Siemens in 2019 for $1.1 billion. But it was hardly an overnight success story; "It took 17 years," he said. "People forget how long it takes sometimes."
When he signed up with Vocalis Health , he said, his wife asked him whether he was certain he didn't want to take a breather. Yet he went ahead anyway; "I liked its disruptive nature."
The disruption is starting to be noticed by the clinical and funding communities. Vocalis Health is about a year removed from receiving $9 million in venture funding, and spent 2020 establishing or cementing research relationships with the Mayo Clinic and the Geisinger Health System in the U.S. Its technology was also the linchpin of an Israeli study of vocal characteristics of congestive heart failure.
Wenderow is not alone in positioning new voice-based analytic technology for wider acceptance. Elsewhere, academic spin-offs and boutique startups are positioning themselves for a remote diagnostic market whose possibilities have rapidly expanded in the socially isolating dynamics of the COVID-19 pandemic. For example: ... '
No comments:
Post a Comment